Press Releases

 

Company News

  Date Title and Summary View
Feb 3, 2006
Columbia, MD - February 3, 2006: CELSION CORPORATION (AMEX: CLN) today announced that, in accordance with the terms of the agreement reached in August 2005, Boston Scientific has advanced the second installment of the US$15 million loan to Celsion. This second installment of US$4.5 million increases the amount drawn down under the loan to US$1...
Jan 19, 2006
Columbia, MD – January 19, 2006: CELSION CORPORATION (AMEX: CLN) today announced that it had appointed William Hahne M.D., as Vice President Clinical Development and Medical Affairs and Christopher Black, Ph.D. as Executive Director, Preclinical Research. Dr. Hahne has extensive experience in the management of clinical trial progr...
Jan 17, 2006
Columbia, MD – January 17, 2006: CELSION CORPORATION (AMEX: CLN) today announced that Augustine Cheung, Ph.D., its founder and Chief Scientific Officer, had resigned his positions as Chief Scientific Officer and a member of the Board of Directors. The Company also announced that Dr. Cheung has acquired 100% of the outstanding shares of Cel...
Dec 8, 2005
Columbia, MD – December 8, 2005: CELSION CORPORATION (AMEX: CLN) today announced that Dr. Lawrence Olanoff, President and Chief Executive Officer will present at the NYSSA 9th Annual Biotech/Specialty Pharma Conference at the Harvard Club of New York City on Thursday, December 14, 2005 at 12:55 local time. Interested parties wi...
Nov 30, 2005
Columbia, MD – November 30, 2005: CELSION CORPORATION (AMEX: CLN) today announced that two studies involving the investigation of ThermoDox in animals will be presented at the 2005 Annual Radiological Society of North America meeting in Chicago (November 27 to December 2, 2005). In the first study to be presented by Victor Fre...
Nov 9, 2005
Columbia, MD – November 9, 2005: CELSION CORPORATION (AMEX: CLN) today announced financial results for its third quarter ended September 30, 2005. The Company reported revenue of $3.2 million for the quarter, compared to $0.5 million for the third quarter of 2004. The Company recorded a net loss for the third quarter of $2.0 m...
Nov 8, 2005
Columbia, MD – November 8, 2005: CELSION CORPORATION (AMEX: CLN) today announced that it had agreed to provide Duke University with a research grant and clinical supplies of ThermoDox, Celsion's proprietary doxorubicin-encapsulated thermo-sensitive liposome, to support a Phase I, open-label study of the safety and pharmacokinetics in pa...
Nov 3, 2005
Columbia, MD – November 3, 2005- Celsion Corporation (AMEX: CLN) today announced that Dr. Lawrence Olanoff, Chief Executive Officer, was interviewed by Wall Street Reporter earlier today. In the interview, Dr. Olanoff elaborated on Celsion's transformation from a medical device company to biopharmaceutical company, solely focuse...
Nov 3, 2005
Wednesday, November 9, 2005 Columbia, MD – November 2, 2005: CELSION CORPORATION (AMEX: CLN) today announced that it would hold its regular quarterly shareholders' conference call at 11:00 a.m. Eastern Time on Wednesday, November 9, 2005. To participate in the call, interested parties can dial 800-366-7449 (domestic) or 303-26...
Aug 9, 2005
COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 9, 2005--CELSION CORPORATION (AMEX:CLN) today announced that it had reached an agreement pursuant to which Boston Scientific Corporation (NYSE:BSX) will lend Celsion up to $15 million. The loan, which has a term expiring on February 20, 2009, will be disbursed in up to three installments and will bear inter...
Page: FirstPrevious ...
43
NextLast
= add release to Briefcase
Share This